The University Hospital of Gran Canaria Doctor Negrín today welcomed the act of delivery of the DISA Foundation Awards for Medical Research, in an act chaired by the president of the Autonomous Government Fernando Clavijo, the Health Advisor José Manuel Baltar and the president of the Raimundo Baroja Foundation.
This is the fourth edition of these grants, which distinguishes eight research projects clinic and transnational carried out in centers of the Archipelago, selected from a total of 32.
In this edition, the Foundation has made an economic investment of more than 150,000 euros, continuing with its objective of promoting scientific knowledge and promoting research in the health field. In addition, it aims to promote the figure of the young researcher, and for this reason, special attention has been given to works led by scientists under 40 years of age, as well as projects of special social and health relevance in the Canary archipelago.
During the act of delivery, the president of the Government of the Canary Islands, Fernando Clavijo, who congratulated the awarded researchers, highlighted the importance of the awards, taking into account that "research and development in the Canary Islands is a pending issue".
For his part, the Minister of Health thanked the DISA Foundation for its commitment to research in the Canary Islands; while congratulating the researchers for the work they do every day "so that the health system is better".
The awards, which were launched in 2015, aim to recognize the merit of Canary scientists "who work tirelessly to improve the quality of life of people, contribute to strengthening the scientific fabric and encourage research activity", affirmed the president of the DISA Foundation, Raimundo Baroja.
In total, eight projects have been distinguished, among them: Evaluation of the causality of variations in cxl12 concentrations in coronary ischemic disease by Mendelian randomization; Study of exercise capacity in patients affected by cystic fibrosis. Keep Walking Project; Person-centered care: Shared decision-making about fertility in women with Cancer of breast; Genetic characterization of patients with congenital heart diseases; Genetic alterations associated with receptor activation of b cells in chronic lymphatic leukemia and their prognostic impact; Pilot study of the identification of initiating mutations and promoters of leukemic stem cells in myelodysplastic syndromes; Repositioning of lipophilic statins in the treatment of acute lymphocytic leukemia: synergism with inhibitors of dihydrofolate reductase; and the Study of the nucleolar protein pict1 as a possible marker in renal carcinoma and its relationship with the histological grade and tumor aggressiveness and the expression of klotho and variants of p53.